Item 1.01 Entry into a Material Definitive Agreement.
On March 8, 2021, Apex Technology Acquisition Corp., a Delaware corporation (the Company) entered into Amendment
No. 2 to the Business Combination Agreement and Plan of Reorganization (the Second Amendment). The Second Amendment amends that certain Business Combination Agreement and Plan of Reorganization (the Business
Combination Agreement), dated November 23, 2020, by and among the Company, Athena Technology Merger Sub, Inc., a Delaware corporation (Merger Sub 1), Athena Technology Merger Sub 2, LLC, a Delaware limited liability
company (Merger Sub 2) and AvePoint, Inc., a Delaware corporation (AvePoint), as amended on December 30, 2020 (the First Amendment). Under the Business Combination Agreement, Merger Sub 1
will be merged with and into AvePoint (the First Merger), with AvePoint surviving the First Merger as a wholly owned subsidiary of the Company, and promptly following the First Merger, AvePoint will be merged with and into Merger
Sub 2 (the Second Merger), with Merger Sub 2 surviving the Second Merger as a wholly owned subsidiary of the Company. The Second Amendment updates certain defined terms to the Business Combination Agreement.
The foregoing description of the Second Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions
of the Second Amendment, a copy of which is attached hereto as Exhibit 2.1, the Business Combination Agreement, which is filed as Exhibit 2.1 to the Companys Current Report on Form 8-K filed with the SEC
on November 23, 2020, and the First Amendment, which is filed as Exhibit 2.1 to the Companys Current Report on Form 8-K filed with the SEC on December 30, 2020, each of which is incorporated
herein by reference.
Important Information About the Business Combination and Where to Find It
In connection with the proposed Business Combination, Apex intends to file the Proxy with the SEC. Apex will mail a definitive proxy statement
and other relevant documents to its stockholders. Apexs stockholders and other interested persons are advised to read the preliminary proxy statement and any amendments thereto and, when available, the definitive proxy statement and documents
incorporated by reference therein filed in connection with the Business Combination, as these materials will contain important information about AvePoint, Apex and the Business Combination. When available, the definitive proxy statement and other
relevant materials for the Business Combination will be mailed to stockholders of AvePoint as of a record date to be established for voting on the Business Combination. INVESTORS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT
MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE TRANSACTION. Stockholders will also be able to obtain copies of the preliminary proxy statement, the
definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SECs website at www.sec.gov, or by directing a request to: Apex Technology Acquisition
Corp., 533 Airport Blvd., Suite 400, Burlingame, CA 94010, Attention: Secretary, (619) 736-6855.
Participants in the Solicitation
Apex and its directors and executive officers may be deemed participants in the solicitation of proxies from Apexs stockholders with
respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in Apex is contained in Apexs annual report on Form 10-K for the
fiscal year ended December 31, 2019, which was filed with the SEC on March 27, 2020 and is available free of charge at the SECs website at www.sec.gov, or by directing a request to Apex Technology Acquisition Corp., 533 Airport
Blvd., Suite 400, Burlingame, CA 94010, Attention: Secretary, (619) 736-6855. Additional information regarding the interests of such participants will be contained in the Proxy.
AvePoint and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders
of Apex in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be included in the Proxy.